Literature DB >> 2991874

Malignant inflammatory fibrous histiocytoma of bone and acute lymphoblastic leukaemia.

B E Woodcock, M A Parsons, D A Winfield.   

Abstract

A patient is described who developed a malignant inflammatory fibrous histiocytoma of vertebral bone (MFH) 4 months after the onset of acute lymphoblastic leukaemia. This is the first report of the simultaneous occurrence of these two conditions. Similarities to the more frequent occurrence of another histiocytic malignancy, histiocytic medullary reticulosis, following acute lymphoblastic leukaemia, are noted. The usefulness of gallium scanning to monitor the response of this tumour to treatment is demonstrated.

Entities:  

Mesh:

Year:  1985        PMID: 2991874      PMCID: PMC2418339          DOI: 10.1136/pgmj.61.717.631

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  Malignant fibrous histiocytoma: an analysis of 200 cases.

Authors:  S W Weiss; F M Enzinger
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

2.  Inflammatory fibrous histiocytoma. An aggressive and lethal lesion.

Authors:  M Kyriakos; R L Kempson
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

3.  Complete recovery of histiocytic medullary reticulosis-like syndrome in a child with acute lymphoblastic leukemia.

Authors:  J A Yin; T O Kumaran; G W Marsh; M Rossiter; D Catovsky
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

4.  Gallium scanning in malignant fibrous histiocytoma.

Authors:  P F Zazzaro; J E Bosworth; V Schneider; J J Zelenak
Journal:  AJR Am J Roentgenol       Date:  1980-10       Impact factor: 3.959

5.  Second malignancy in acute lymphocytic leukemia. Review of 33 cases.

Authors:  A D Mosijczuk; F B Ruymann
Journal:  Am J Dis Child       Date:  1981-04

Review 6.  Second neoplasms in acute lymphoblastic leukemia.

Authors:  M H Zarrabi; F Rosner; H W Grünwald
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.